The Daily Fuckup

The White House announced a pharmaceutical tariff proclamation on April 2 that would put a future tax wall around certain patented drugs and their ingredients, but not immediately and not without conditions. The order says the tariffs are meant to address national security concerns tied to foreign reliance in pharmaceutical supply chains, while also pushing companies toward U.S. production. ([whitehouse.gov](https://www.whitehouse.gov/presidential-actions/2026/04/adjusting-imports-of-pharmaceuticals-and-pharmaceutical-ingredients-into-the-united-states/))

Under the proclamation, a 100% ad valorem duty rate is set for patented pharmaceuticals and associated pharmaceutical ingredients listed in the order, unless another provision applies. But the policy is phased in. For companies in Annex III, the tariff framework takes effect July 31, 2026; for other companies, it takes effect September 29, 2026. The proclamation also sets a 20% duty for certain companies with approved onshoring plans, which would rise to 100% four years later. ([whitehouse.gov](https://www.whitehouse.gov/presidential-actions/2026/04/adjusting-imports-of-pharmaceuticals-and-pharmaceutical-ingredients-into-the-united-states/))

The White House also said some companies that have fully executed agreements, or are negotiating agreements, on most-favored-nation pricing and onshoring of production and research and development will face no tariffs for now. The proclamation says generic pharmaceuticals and biosimilars are not being adjusted at this time and are not subject to Section 232 tariffs at present. ([whitehouse.gov](https://www.whitehouse.gov/presidential-actions/2026/04/adjusting-imports-of-pharmaceuticals-and-pharmaceutical-ingredients-into-the-united-states/))

The practical result is less a sudden border hit than a staged tariff threat aimed at steering manufacturing decisions. Drug makers, importers, hospitals and patients still face uncertainty, but the official timeline matters: the action was announced on April 2, not April 5, and the tariff structure does not snap into place all at once. ([whitehouse.gov](https://www.whitehouse.gov/presidential-actions/2026/04/adjusting-imports-of-pharmaceuticals-and-pharmaceutical-ingredients-into-the-united-states/))